These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 1437752

  • 1. [Recurrences after completion of the treatment of acute lymphoblastic leukemia in children].
    Ochocka M, Matysiak M, Newecka-Samól T, Kulus M, Armata J, Balwierz W, Bogusławska-Jaworska J, Chybicka A, Jackowska T, Jakowicka M.
    Pol Tyg Lek; ; 47(16-17):350-3. PubMed ID: 1437752
    [Abstract] [Full Text] [Related]

  • 2. [Second cessation of therapy in children with acute lymphoblastic leukemia].
    Rokicka-Milewska R, Derulska D, Jackowska T, Armata J, Balwierz W, Bogusławska-Jaworska J, Chybicka A, Cyklis R, Duczmal B, Jakowicka M.
    Acta Haematol Pol; 1992; 23(1):43-7. PubMed ID: 1615750
    [Abstract] [Full Text] [Related]

  • 3. [The fate of children after discontinuation of treatment for acute lymphoblastic leukemia].
    Derulska D, Rokicka-Milewska R, Jackowska T, Armata J, Balwierz W, Bogusławska-Jaworska J, Chybicka A, Cyklis R, Darmal B, Jakowicka M.
    Acta Haematol Pol; 1991; 22(2):223-32. PubMed ID: 1841493
    [Abstract] [Full Text] [Related]

  • 4. [Preliminary evaluation of the treatment of recurrences of acute lymphoblastic leukemia by the BFM (Henze) method].
    Ochocka M, Zelenay E.
    Pediatr Pol; 1988 Nov; 63(11):716-22. PubMed ID: 3253658
    [No Abstract] [Full Text] [Related]

  • 5. [Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group].
    Skoczeń S, Balwierz W, Moryl-Bujakowska A, Pawińska K, Luszczyńska A, Balcerska A, Płoszyńska A, Chybicka A, Dobaczewski G, Juszczak K, Wachowiak J, Derwich K, Kowalczyk J, Wiśniewska-Slusarz H, Matysiak M, Krauze A, Pawelec K, Sońta-Jakimczyk D, Tomaszewska R, Wysocki M, Styczyńskii J, Swiatkiewicz V, Polish Pediatric Leukemia/Lymphoma Study Group.
    Przegl Lek; 2006 Nov; 63(1):11-4. PubMed ID: 16892892
    [Abstract] [Full Text] [Related]

  • 6. [Results and experiences with a modified BFM protocol for treatment of recurrences in children with acute lymphoblastic leukemia in East German areas].
    Sauerbrey A, Zintl F, Malke H, Reimann M, Maaser M, Domula M, Dörffel W, Eggers G, Exadaktylos P, Kotte W.
    Klin Padiatr; 1993 Nov; 205(4):281-7. PubMed ID: 8377448
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
    van der Does-van den Berg A, van Wering ER, Suciu S, Solbu G, van 't Veer MB, Rammeloo JA, de Koning J, van Zanen GE.
    Am J Pediatr Hematol Oncol; 1989 Nov; 11(2):125-33. PubMed ID: 2665546
    [Abstract] [Full Text] [Related]

  • 8. [Study of reinduction chemotherapy in bone marrow relapse of childhood acute lymphoblastic leukemia].
    Sato Y, Ito R, Saito T, Suto Y, Tateoka N, Onodera N, Ikeda Y, Ito E, Miyano T, Tachibana N.
    Rinsho Ketsueki; 1989 Nov; 30(11):1923-30. PubMed ID: 2607611
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.
    Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi A, Miniero R, Di Tullio MT, Lo Nigro L, Pession A, Rondelli R, Messina C, Santoro N, Mori PG, De Rossi G, Tamaro P, Silvestri D, Biondi A, Basso G, Masera G.
    Haematologica; 1998 Sep; 83(9):791-9. PubMed ID: 9825576
    [Abstract] [Full Text] [Related]

  • 11. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Sancho JM, Ribera JM, Xicoy B, Morgades M, Oriol A, Tormo M, del Potro E, Debén G, Abella E, Bethencourt C, Ortín X, Brunet S, Ortega-Rivas F, Novo A, López R, Hernández-Rivas JM, Sanz MA, Feliu E, PETHEMA Group.
    Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
    [Abstract] [Full Text] [Related]

  • 12. Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87.
    Schaison G, Sommelet D, Bancillon A, Perel Y, Leblanc T, Bergeron C, Lejars O, Baruchel A, Lepage E, Leverger G.
    Leukemia; 1992 Feb; 6 Suppl 2():148-52. PubMed ID: 1578919
    [No Abstract] [Full Text] [Related]

  • 13. Induction toxicity of a modified Memorial Sloan-Kettering-New York II Protocol in children with relapsed acute lymphoblastic leukemia: a single institution study.
    Morland BJ, Shaw PJ.
    Med Pediatr Oncol; 1996 Sep; 27(3):139-44. PubMed ID: 8699989
    [Abstract] [Full Text] [Related]

  • 14. Acute lymphoblastic leukemia in children below two years of age.
    Derulska D, Rokicka-Milewska R, Lewicki Z, Jackowska T, Armata J, Bogusławska-Jaworska J, Chybicka A, Kubiczek K, Ochocka M, Radwańska U.
    Acta Haematol Pol; 1990 Sep; 21(1):1-9. PubMed ID: 2260400
    [Abstract] [Full Text] [Related]

  • 15. Acute lymphoblastic leukemia: dental health of children in maintenance therapy.
    Sepet E, Aytepe Z, Ozerkan AG, Yalman N, Guven Y, Anak S, Devecioglu O, Agaoglu L, Gedikoglu G.
    J Clin Pediatr Dent; 1998 Sep; 22(3):257-60. PubMed ID: 9641104
    [Abstract] [Full Text] [Related]

  • 16. [Prognostic value of the reaction to steroids in the treatment of acute lymphoblastic leukemia in children].
    Urasiński T, Peregud-Pogorzelski J, Bartoszewicz L.
    Pol Tyg Lek; 1998 Sep; 47(16-17):360-2. PubMed ID: 1437754
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Acute lymphoblastic leukaemia in Danish children and young people 10 to 19 years of age. Should young adults with acute lymphoblastic leukaemia be treated in the same way as children?].
    Schrøder H, Kjeldstad M, Boesen AM, Nielsen OJ, Schmidt KG, Johnsen HE, Gregersen H, Gustafsson G.
    Ugeskr Laeger; 2006 Jun 26; 168(26-32):2554-8. PubMed ID: 16824410
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.
    Ribera JM, Oriol A, Sanz MA, Tormo M, Fernández-Abellán P, del Potro E, Abella E, Bueno J, Parody R, Bastida P, Grande C, Heras I, Bethencourt C, Feliu E, Ortega JJ.
    J Clin Oncol; 2008 Apr 10; 26(11):1843-9. PubMed ID: 18398150
    [Abstract] [Full Text] [Related]

  • 20. Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study.
    Heath JA, Steinherz PG, Altman A, Sather H, Jhanwar S, Halpern S, Pieters R, Shah N, Steinherz L, Tannous R, Terry W, Trigg ME, Children's Cancer Group.
    J Clin Oncol; 2003 Apr 15; 21(8):1612-7. PubMed ID: 12697887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.